 Measurement vivo urological tumour cell kinetics multiparameter flow cytometry Preliminary study vivo labelling urological tumour cells phase marker bromodeoxyuridine BRdU histochemical studies use multiparameter flow cytometry FCM BRdU tumour proliferation offers significant advantages simultaneous measurements DNA ploidy DI duration phase Ts potential doubling time Tpot total aneuploid tumour labelling indices LI single specimen Heterogenous tumour cell populations high sensitivity preliminary study method measurement kinetics transitional cell carcinoma bladder TCCB Nineteen patients TCCB leukoplakia bladder renal carcinoma prostatic carcinoma squamous carcinoma penis bladder tumours aneuploid DI BRdU uptake tumours median LI range tumours profile satisfactory calculation Ts Tpot median Ts median Tpot days study measurement multiple parameters urological tumour proliferation vivo possible parameters assessment indices biological aggressiveness clinical prognosis